- Home
- LRHC vs PPBT Comparison
LRHC vs PPBT Comparison
Compare LRHC & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- PPBT
- Stock Information
- Founded
- LRHC 2004
- PPBT 2010
- Country
- LRHC United States
- PPBT Israel
- Employees
- LRHC N/A
- PPBT N/A
- Industry
- LRHC
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- PPBT Health Care
- Exchange
- LRHC Nasdaq
- PPBT Nasdaq
- Market Cap
- LRHC 7.3M
- PPBT 7.4M
- IPO Year
- LRHC 2023
- PPBT N/A
- Fundamental
- Price
- LRHC $3.89
- PPBT $0.80
- Analyst Decision
- LRHC
- PPBT Strong Buy
- Analyst Count
- LRHC 0
- PPBT 1
- Target Price
- LRHC N/A
- PPBT $33.00
- AVG Volume (30 Days)
- LRHC 17.3K
- PPBT 21.7M
- Earning Date
- LRHC 11-19-2025
- PPBT 11-06-2025
- Dividend Yield
- LRHC N/A
- PPBT N/A
- EPS Growth
- LRHC N/A
- PPBT N/A
- EPS
- LRHC N/A
- PPBT N/A
- Revenue
- LRHC $78,037,079.00
- PPBT N/A
- Revenue This Year
- LRHC N/A
- PPBT N/A
- Revenue Next Year
- LRHC N/A
- PPBT N/A
- P/E Ratio
- LRHC N/A
- PPBT N/A
- Revenue Growth
- LRHC 54.92
- PPBT N/A
- 52 Week Low
- LRHC $3.66
- PPBT $0.53
- 52 Week High
- LRHC $95.20
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- LRHC 35.23
- PPBT 50.37
- Support Level
- LRHC $3.66
- PPBT $0.71
- Resistance Level
- LRHC $4.41
- PPBT $0.89
- Average True Range (ATR)
- LRHC 0.46
- PPBT 0.12
- MACD
- LRHC -0.13
- PPBT 0.02
- Stochastic Oscillator
- LRHC 21.92
- PPBT 25.71
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.